Regulatory costs and uneven growth shape U.S. business markets

Summary

Alibaba agreed to pay $600 million to resolve a US Justice Department probe into illegal drug listings on its platforms. The company admitted it failed to prevent roughly 80,000 product sales tied to illicit drugs.

Why it matters

The settlement raises the effective regulatory price of running a global marketplace in the US, with direct implications for compliance budgets, platform risk, and cross-border e-commerce growth.

Summary

Nike’s running category is outperforming other parts of the business and is emerging as the clearest driver of the company’s broader turnaround. Investors and analysts see traction in product and demand, but remain skeptical that running alone can deliver enough growth to reset Nike’s overall revenue trajectory.

Why it matters

Nike’s valuation case now hinges on whether a single winning category can scale into companywide growth instead of masking weakness elsewhere.

Summary

Nike told investors it expects a $986 million tariff refund, even as it reported flat full-year revenue of $46.4 billion and a 2% decline on a currency-neutral basis. Management warned tariffs still act as a volatile cost headwind despite the one-time benefit.

Why it matters

A nearly $1 billion refund can mask operating weakness and reshape near-term capital returns, but it raises the risk of misreading Nike's true earnings power.

Summary

Jersey Mike’s has filed to go public, with Blackstone seeking a valuation of up to about $12bn. The offering would monetize Blackstone’s private equity stake in the fast growing sandwich chain.

Why it matters

This IPO is a real time test of whether public investors will pay private equity valuations for consumer growth, shaping the next wave of sponsor exits.